| 763968 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
111 Armored CAR T cells secreting 4–1BB ligand crosslinked to PD-1 checkpoint inhibitor for enhanced solid tumor efficacy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.111 |
Dunn Zachary, Qu Yun, MacMullan Melanie, Chen Xianhui, Cinay Gunce, Wang Pin |
| 763967 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
108 Fast and accurate prediction of optimal CAR T-cell function using z-Movi® Cell Avidity Analyzer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.108 |
Singleterry Will, Candelli Andrea, Reijmers Rogier, Eberlein Jens |
| 763966 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
845 A colony stimulating factor 1 receptor-blocking bifunctional protein simultaneously targets tumor-associated macrophages and exhausted T cells for the treatment of triple-negative breast cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.845 |
Koni Pandelakis, Chen Hung-Kai, Chang Yao-Wen, Hsiao Huey-Wen, Hsiao Chih-Lun, Huang Jing-Yi, Chen Ju-Pei, Yang Muh-Hwa |
| 763965 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
844 A trispecific ROR1 x CD3 T cell engager mediates in vitro tumor cell killing and in vivo tumor eradication |
2021-11-01 |
10.1136/jitc-2021-sitc2021.844 |
Chatterjee Bithi, Snell Daniel, Snell Daniel, Hess Christian, Brock Matthias, Spiga Fabio, Simonin Alexandre, Gunde Tea, Warmuth Stefan, Weinert Christopher, Bassler Nicole, Kirk Niels, Schumacher Nina, Mahler Dana, Yaman Yasemin, Bommer Bettina, Gambino Giorgio, Giezendanner Noreen, Kuettner Benjamin, Flueckiger Naomi, Heiz Robin, Wagen Sandro, Diem Dania, Zeberer Julia, Urech David |
| 763964 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
842 Exosome mediated reprogramming of tumor associated macrophages by exoASO-STAT6 for the treatment of hepatocellular carcinoma (HCC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.842 |
Kamerkar Sushrut, Leng Charan, Zhang Kelvin, Burenkova Olga, Jang Su Chul, Kasera Samuel, Zi Tong, Economides Kyriakos, Soos Timothy, Burzyn Dalia, Sathyanaryanan Sriram |
| 763963 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
841 Targeting the intersection of immunology and redox biology: therapeutic potential of an anti-thioredoxin antibody |
2021-11-01 |
10.1136/jitc-2021-sitc2021.841 |
Willman Gabriella, Davidson Max, Trkulja Carolina, Orwar Owe, Bhat Sachin |
| 763962 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
840 A therapeutic humanized anti-carcinoma monoclonal antibody (mAb) can also identify immunosuppressive regulatory T (Tregs) cells and down regulate Treg-mediated immunosuppression |
2021-11-01 |
10.1136/jitc-2021-sitc2021.840 |
Tsang Kwong, Fantini Massimo, Cole Christopher, Annunziata Christina, Arlen Philip |
| 763961 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
839 Microbiota-specific T follicular helper cells drive tertiary lymphoid structure formation and anti-tumor immunity in colorectal cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.839 |
Overacre-Delgoffe Abigail, Bumgarner Hannah, Cillo Anthony, Burr Ansen, Tometich Justin, Bhattacharjee Amrita, Bruno Tullia, Vignali Dario, Hand Timothy |
| 763960 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
838 The role of microbiota in metastatic brain tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.838 |
Johnson Sarah, Morad Golnaz, Ajami Nadim, Wargo Jennifer, Wong Matthew, Lastrapes Matthew |
| 763959 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
837 Preliminary insights into the impact of tumor microbiome in head and neck squamous cell carcinoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.837 |
Karivedu Vidhya, Hoyd Rebecca, Wheeler Caroline, Jhawar Sachin, Bhateja Priyanka, Bonomi Marcelo, Spakowicz Daniel |
